3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Polycythemia Vera
8
Leukemia, Myeloid, Chronic-Phase
7
Leukemia
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Thrombocythemia, Essential
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Thrombosis
1
Primary Myelofibrosis
1
Polycythemia
1
Pharyngeal Neoplasms
1
Paranasal Sinus Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Laryngeal Neoplasms
1
Glioblastoma
1
Congenital Abnormalities
1
Brain Neoplasms
1
Astrocytoma
1
Anemia, Refractory, with Excess of Blasts
1
Adenocarcinoma
1
Interventions
Radiotherapy
5
Cisplatin
5
Magnetic Resonance Spectroscopy
3
Fluorouracil
3
Cetuximab
3
Carboplatin
3
pembrolizumab
2
Taxes
2
Surgical Procedures, Operative
2
Specimen Handling
2
Paclitaxel
2
Drug Therapy
2
Docetaxel
2
(225)Ac-DOTA-c(RGDyK)
2
sargramostim
1
dehydroftorafur
1
Tretinoin
1
Sucralfate
1
Salts
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Adjuvant
1
Radiation
1
Platinum
1
Neoadjuvant Therapy
1
Laryngectomy
1
Hydroxyurea
1
Chemoradiotherapy
1
Cefazolin
1
Adjuvants, Pharmaceutic
1
5-fluoro-3-pyridinecarboxylic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Laryngeal Neoplasms
×
Hydroxyurea
×
Clear all
NCT00117572
2018-04-09
DeCIDE
University of Chicago
Phase 3
Completed
285 enrolled
22 charts